These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5918903)

  • 61. [Metabolic changes following irradiation of the pituitary gland with yttrium isotopes for diabetic retinopathy].
    Dub O; Pátek F
    Vnitr Lek; 1969 Nov; 15(11):1082-8. PubMed ID: 5364828
    [No Abstract]   [Full Text] [Related]  

  • 62. Destruction of the hypophysis with implants of pure 90Y metal.
    Notter G; Melander O; Johansson L
    Acta Radiol Ther Phys Biol; 1968 Feb; 7(1):17-21. PubMed ID: 5672723
    [No Abstract]   [Full Text] [Related]  

  • 63. Early pituitary implantation for advanced breast cancer.
    Stewart HJ; Forrest AP; Chinnock-Jones RE; Benson EA; Jones V; Kunker PB; Campbell H
    Br J Surg; 1969 May; 56(5):389. PubMed ID: 5781084
    [No Abstract]   [Full Text] [Related]  

  • 64. [New biological evidence on the hormone dependence of breast cancer (preliminary note)].
    Juret P; Hayem M
    Rev Fr Etud Clin Biol; 1968 Nov; 13(9):884-7. PubMed ID: 5709512
    [No Abstract]   [Full Text] [Related]  

  • 65. PITUITARY DESTRUCTION BY SCREW IMPLANTATION WITH YTTRIUM-90.
    BLAIR DW
    J R Coll Surg Edinb; 1963 Jul; 8():319-21. PubMed ID: 14044130
    [No Abstract]   [Full Text] [Related]  

  • 66. [Technics and results of radioactive implants in the pituitary for advanced carcinomas of the breast and prostate and for pituitary tumors].
    Scheer KE
    Minerva Med; 1967 Dec; 58(99):4526-8. PubMed ID: 6082432
    [No Abstract]   [Full Text] [Related]  

  • 67. [THE METOPIRONE TEST IN BREAST CANCER OF AN ADVANCED STAGE, BEFORE AND AFTER PITUITARY IMPLANTATION OF YTTRIUM].
    POMMATAU E; POULAIN S; COLON J
    Lyon Med; 1963 Nov; 210():1005-17. PubMed ID: 14097631
    [No Abstract]   [Full Text] [Related]  

  • 68. [On the palliative treatment of breast carcinoma with general metastases using hypophyseal blockade through radiogold seed implantation].
    Keinert K; Kirsch M; Schumann E; Usbeck W
    Strahlentherapie; 1967 Feb; 132(2):200-5. PubMed ID: 4175223
    [No Abstract]   [Full Text] [Related]  

  • 69. Yttrium-90 pituitary ablation in advanced carcinoma of the prostate.
    Morales A; Blair DW; Steyn J
    Br J Urol; 1971 Oct; 43(5):520-2. PubMed ID: 5118130
    [No Abstract]   [Full Text] [Related]  

  • 70. THERAPEUTIC HYPOPITUITARISM INDUCED BY STEREOTAXIC TRANSFRONTAL IMPLANTATION OF YTTRIUM-90 IN PATIENTS WITH BREAST CANCER.
    JADRESIC A; POBLETE M; REID A; RIERA M; MATUS A; HERREROS M
    J Clin Endocrinol Metab; 1965 May; 25():686-97. PubMed ID: 14313763
    [No Abstract]   [Full Text] [Related]  

  • 71. [Hypophysiolysis by radioactive yttrium implantation in treatment of advanced breast cancer: 10 years' record].
    Juret P
    Probl Actuels Endocrinol Nutr; 1969; 13():373-93. PubMed ID: 5404030
    [No Abstract]   [Full Text] [Related]  

  • 72. Implantation of yttrium in an acromegalic patient.
    Gélinas JJ; McCullagh EP; Dohn DF
    Cleve Clin Q; 1966 Oct; 33(4):171-8. PubMed ID: 5976948
    [No Abstract]   [Full Text] [Related]  

  • 73. PITUITARY IMPLANTATION OF RADIOACTIVE ISOTOPES FOR MEDICAL DISEASES.
    FALCONER MA
    Proc R Soc Med; 1965 Jan; 58(1):62-3. PubMed ID: 14267503
    [No Abstract]   [Full Text] [Related]  

  • 74. Result from treatment of Cushing's disease with radioactive gold and radioactive yttrium.
    Joplin GF
    Acta Isot (Padova); 1964 Dec; 4(4):347-54. PubMed ID: 5849081
    [No Abstract]   [Full Text] [Related]  

  • 75. [Intrasellar application of radioactive isotopes from a functional standpoint (mammary carcinoma, malignant exophthalmos, Cushing's syndrome, diabetes, malignant arterial hypertension)].
    Talairach J; Szikla G
    Nucl Med (Stuttg); 1965; ():Suppl 2:371+. PubMed ID: 5888923
    [No Abstract]   [Full Text] [Related]  

  • 76. [Results of treatment of malignant exophthalmos by intrasellar implantation of yttrium 90].
    Molinatti GM
    Acta Isot (Padova); 1964 Dec; 4(4):399-416. PubMed ID: 5898108
    [No Abstract]   [Full Text] [Related]  

  • 77. [Partial radioresection of the pituitary by yttrium 90 for the therapy of Cushing's syndrome].
    Börner W; Kleinfelder H; Nadjmi M; Husmann F
    Nucl Med (Stuttg); 1965; ():Suppl 2:391+. PubMed ID: 4870636
    [No Abstract]   [Full Text] [Related]  

  • 78. Pituitary ablation by 90 yttrium implantation for advancing diabetic retinopathy. A preliminary report.
    Cullen JF; Harris P; Turner JW; Donaldson AA; Munro JF; Duncan LJ
    Br J Ophthalmol; 1965 Aug; 49(8):405-12. PubMed ID: 5826892
    [No Abstract]   [Full Text] [Related]  

  • 79. TRANS-SPHENOIDAL HYPOPHYSECTOMY.
    BATEMAN GH
    J Otolaryngol Soc Aust; 1964 Sep; 1():256-60. PubMed ID: 14234119
    [No Abstract]   [Full Text] [Related]  

  • 80. Pituitary tumour treated by pituitary implantation of yttrium 90 during or before pregnancy (two cases).
    Burke CW; Joplin GF; Fraser R
    Proc R Soc Med; 1972 May; 65(5):486-8. PubMed ID: 4117301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.